| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/24/2005 | EP1565445A1 Novel process for the preparation of imidazolyl compounds |
| 08/24/2005 | EP1565443A2 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 08/24/2005 | EP1565433A2 Novel ligands that are antagonists of rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 08/24/2005 | EP1565431A1 Cannabinoid receptor ligands |
| 08/24/2005 | EP1565239A2 Liquid pharmaceutical formulations containing 3,7-diazabicyclo'3,3,1! nonanes for treating anti-arrhythmic events |
| 08/24/2005 | EP1565215A2 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 08/24/2005 | EP1565212A1 Gastrin compositions and formulations, and methods of use and preparation |
| 08/24/2005 | EP1565201A1 Methods of administering dalbavancin for treatment of bacterial infections |
| 08/24/2005 | EP1565195A1 Anticancer or antiviral composition |
| 08/24/2005 | EP1565194A1 Aqueous activated components conveyed in a non-aqueous carrier system |
| 08/24/2005 | EP1565193A2 Methods and compositions for treating cancer using proteasome inhibitors |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565191A1 Delivery composition and method |
| 08/24/2005 | EP1565190A2 Arylcyclopropylcarboxylic amides as potassium channel openers |
| 08/24/2005 | EP1565189A1 Anti-aging skin care composition and uses thereof |
| 08/24/2005 | EP1565188A2 Methods for the treatment, prevention and management of macular degeneration |
| 08/24/2005 | EP1565187A2 Methods of treating cancer and related methods |
| 08/24/2005 | EP1565185A2 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 08/24/2005 | EP1565184A1 Treatment of headache with antipsychotics delivered by inhalation |
| 08/24/2005 | EP1565183A1 Rapamycin and il-10 for the treatment of immune diseases |
| 08/24/2005 | EP1565182A1 Treatment of gastrointestinal disorders with duloxetine |
| 08/24/2005 | EP1565181A2 Deguelin as a chemopreventive agent for lung cancer |
| 08/24/2005 | EP1565180A2 A method for inhibiting cancer development by fatty acid synthase inhibitors |
| 08/24/2005 | EP1565179A1 Composition comprising a carbamic acid derivative, its use as cosmetic and medicine |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1565177A1 Use of pharmaceutical compositions containing ethyl esters of omega-3 polyunsaturated acids to prevent atrial fibrillation |
| 08/24/2005 | EP1565176A1 Agent having a destructive effect on malignant tumors and method for the production thereof |
| 08/24/2005 | EP1565175A1 Use of a histone deacetylase inhibitor for treating muscular dystrophies |
| 08/24/2005 | EP1565174A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 08/24/2005 | EP1565173A2 Composition and its use for treating neuropathic sensory loss |
| 08/24/2005 | EP1565172A2 Suppression of cytotoxic protein conformers |
| 08/24/2005 | EP1565171A2 Controlled absorption of mixed thyroyd hormone formulations |
| 08/24/2005 | EP1565170A1 Selective cyclooxygenase-2 inhibitor patch |
| 08/24/2005 | EP1565169A1 Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor, e.g. parecoxib and valdecoxib |
| 08/24/2005 | EP1565168A1 Pharmaceutical tablets containing tibolone and a coating |
| 08/24/2005 | EP1565166A1 Solid particulate antifungal compositions for pharmaceutical use |
| 08/24/2005 | EP1565165A2 Liposomal formulations |
| 08/24/2005 | EP1565162A1 Microemulsion composition for oral administration of biphenyldimethyldicarboxylate |
| 08/24/2005 | EP1565158A1 Oxazolidinones for cosmetic and pharmaceutical use in skin pathologies |
| 08/24/2005 | EP1565136A2 Compositions and methods for transdermal oxybutynin therapy |
| 08/24/2005 | EP1565055A2 Compounds for the treatment of tobacco dependence and withdrawal |
| 08/24/2005 | EP1504019B1 Platinum complexes having antitumor activity |
| 08/24/2005 | EP1497289B1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
| 08/24/2005 | EP1468003B1 Phosphinic pseudo-peptide derivatives |
| 08/24/2005 | EP1458713B1 Indolinone derivatives useful as protein kinase inhibitors |
| 08/24/2005 | EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 08/24/2005 | EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 08/24/2005 | EP1372624B1 Tramadol-based medicament |
| 08/24/2005 | EP1370558B1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/24/2005 | EP1360185B1 Carboline derivatives |
| 08/24/2005 | EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 08/24/2005 | EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 08/24/2005 | EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity |
| 08/24/2005 | EP1335917B1 Condensed pyridoindole derivatives |
| 08/24/2005 | EP1334085B1 Sulfamides as gamma-secretase inhibitors |
| 08/24/2005 | EP1330435B1 Crystalline forms of fluvastatin sodium |
| 08/24/2005 | EP1317413B1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/24/2005 | EP1299349B1 Compounds to treat alzheimer's disease |
| 08/24/2005 | EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 08/24/2005 | EP1284722B1 Compositions containing a benzamide disulfide derivative for treating allergic diseases |
| 08/24/2005 | EP1280779B1 New polycyclic indanylimidazoles with alpha2 adrenergic activity |
| 08/24/2005 | EP1276749B1 Photo-labile coumarinylmethyl esters of cyclic nucleotides, method for the production and use thereof |
| 08/24/2005 | EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 08/24/2005 | EP1263742B1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/24/2005 | EP1254146B1 Processes for preparing clarithromycin polymorphs and novel polymorph iv |
| 08/24/2005 | EP1244652B1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 08/24/2005 | EP1242085B1 Benzimidazole compounds having nociceptin receptor affinity |
| 08/24/2005 | EP1218341B1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 08/24/2005 | EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 08/24/2005 | EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 08/24/2005 | EP1204426B1 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
| 08/24/2005 | EP1190248B1 Screening methods for compounds which affect melanogenesis |
| 08/24/2005 | EP1187803B1 Amorphous nitric esters and their pharmaceutical compositions |
| 08/24/2005 | EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 08/24/2005 | EP1163218B1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine |
| 08/24/2005 | EP1146859B1 Method of preparing particles for agglomeration |
| 08/24/2005 | EP1144394B1 1-heterocycle substituted diarylamines |
| 08/24/2005 | EP1143925B1 Topical composition comprising n-acetylglucosamine |
| 08/24/2005 | EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 08/24/2005 | EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 08/24/2005 | EP1077675B1 Compositions for the treatment of acne |
| 08/24/2005 | EP1074631B1 Compounds having glucuronic acid derivatives and glucosamine derivatives in the structure, process for producing the same and utilization thereof |
| 08/24/2005 | EP1072266B1 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments |
| 08/24/2005 | EP1032406B1 Reducing blood cholesterol by in vivo precipitation of bile constituents with group ii or -iii metal substances |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | EP1001770B1 Tazarotene and uvb phototherapy treatment for psoriasis |
| 08/24/2005 | EP0998271B1 Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs |
| 08/24/2005 | EP0996438B1 Use of cis-6-hexadecenoic acid esters for treating psoriasis, allergies, auto-immune disorders and dry, sensitive skin |
| 08/24/2005 | EP0979654B1 Activated vitamin d 3 emulsion-type lotions |
| 08/24/2005 | EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways |
| 08/24/2005 | EP0804436B1 Guanine derivative |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | EP0684955B1 Nuclear matrix proteins |
| 08/24/2005 | EP0681483B1 Compositions and methods for delivery of genetic material |
| 08/24/2005 | CN1659288A Method to inhibit cell growth using oligonucleotides |
| 08/24/2005 | CN1659181A 9-alpha-substituted estratrienes as selectively active estrogens |
| 08/24/2005 | CN1659178A 6, 11 bicyclic erythromycin derivatives |
| 08/24/2005 | CN1659177A Gangliosides with a modified acyl function |
| 08/24/2005 | CN1659176A Condensed palatinose and method for producing the same |
| 08/24/2005 | CN1659171A Specific cyclolignans for treating insulin-like growth factor-1 receptor dependent diseases |